Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
YF-S0 Potential treatment - pre-clinical evidence Experimental Vaccine Dec/01/2020 1 0
Wogonin Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 1 0
WNbFc 7 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 36 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 2 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 15 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
Withanone Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021 1 0
WiNeWsE Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021 1 0
W4P-RBD Potential treatment - pre-clinical evidence Experimental Vaccine Feb/26/2021 1 0
VSV-eGFP-SARS-CoV-2 Potential treatment - pre-clinical evidence Experimental Vaccine Jul/30/2020 1 0